Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)

NCT00774020 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Paget's Disease of Bone

Interventions

DRUG: Zoledronic acid

Sponsor

Novartis Pharmaceuticals